The VA will not expand its cannabis research, despite recent bipartisan calls from Congress, doctors and veterans. The recent withdrawal from Afghanistan has exacerbated the demand for more understanding of cannabis for treatment, however, without research, the VA continues to deny cannabis recommendations to veterans in 36 states that allow medical marijuana, reported Politico.
Rep. Lou Correa (D-Calif.) introduced a bill that would instruct the VA to study cannabis for PTSD, depression and a number of other conditions. At the same time, Sen. Brian Schatz (D-Hawaii) introduced an amendment to a must-pass defense spending bill that would allow VA physicians to recommend medical marijuana under state-regulated programs and conduct research.
“The VA keeps saying, 'We have the authority, we don't need you to micromanage us.’ But we do — because they're not doing their job," Correa said.
Veterans say that has forced many to suffer, while some researchers suggest the VA also may be ignoring potential ill effects when used inappropriately, wrote Politico.
Meanwhile, the Department of Veterans Affairs (VA) confirmed in a report that at least 60,000 veterans had died by suicide between 2008 and 2017. Currently, 17 to 20 veterans per day take their own lives, reports the VA.
The VA seems to find the new legislation to be redundant and therefore unnecessary. As stated in testimony: “The proposed legislation is redundant to the extent that VA is already examining risks and benefits of cannabis in treating PTSD and chronic pain. For these reasons, VA does not support this proposed legislation.”
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.